USP18 and hepatocellular carcinoma: In this study, we discovered that sorafenib promotes the accumulation of USP18 in HCC cells by inducing ISG15 mRNA expression, which prevents the ubiquitination and subsequent degradation of USP18, rather than through transcriptional regulation (Fig. 1D and Fig. 5A–H).